Clinical Data Sells IVD Business for $20M as Part of Plan to Focus on PGx Rx and Dx Plays | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data today said it has sold its Netherlands-based in vitro diagnostics business Vital Scientific to French company ELITech Group for $19.5 million in cash.
 
The actual sale price was $15 million, but Clinical Data said it retained $4.5 million in cash from Vital Scientific immediately before the sale.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.